Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of two finafloxacin regimens versus ciprofloxacin for hospitalized complicated urinary tract infection or acute pyelonephritis
2011-006041-14Phase 2Completed
- Sponsor
- MerLion Pharmaceuticals
- Start
- Jul 2012
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of finafloxacin and ciprofloxacin in complicated urinary tract infection (cUTI) and acute pyelonephritis (3 arms), sponsored by MerLion Pharmaceuticals. Started Jul 2012; status: completed.
02
Drugs
finafloxacinciprofloxacin
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on 2011-006041-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006041-14.